Dysplastic nevi and melanoma: microRNAs tell a divergent story

Giorgio Durante1, Giulia Veronesi2, Cosimo Misciali2

  • 1Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna 40100, Italy.

Abstract

Insights

Dysplastic nevi (DN) have a distinct microRNA (miRNA) expression profile, separate from melanoma. This suggests dysplastic nevi are unique biological entities, not precursors to melanoma.

Area of Science:

  • Molecular biology
  • Dermatology
  • Oncology

Background:

  • Dysplastic nevi (DN) share features with melanoma, but their role as precursors is debated.
  • Uncertainty leads to excessive excision of DN with severe atypia.
  • MicroRNAs (miRNAs) are key regulators of gene expression and can classify tissue types.

Purpose of the Study:

  • To investigate tumor evolution by comparing global microRNA expression in DN and invasive melanomas from the same patient.
  • To assess if DN represent distinct biological entities or melanoma precursors.

Main Methods:

  • Small-RNA sequencing was performed on 6 DN, 2 congenital nevi, and 4 cutaneous melanomas from 4 subjects.
  • Global miRNA expression correlation between samples was evaluated.

Main Results:

  • Hierarchical clustering and principal component analyses grouped DN and their matching congenital nevi separately from melanomas.
  • DN exhibited a distinct miRNA expression profile compared to melanomas from the same patient.

Conclusions:

  • Dysplastic nevi possess a unique miRNA expression profile, differentiating them from melanomas.
  • Findings support the hypothesis that DN are distinct biological entities, not melanoma precursors.
  • This research may inform clinical decisions regarding the management of dysplastic nevi.